Pancreatic Cancer Research

ResearcherJiangnan UniversityActive in the last 2 years

Tu Dai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8695-7783; OpenAlex author ID A5101543157. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 4

  1. Retraction Note: Upregulation of ARHGAP30 attenuates pancreatic cancer progression by inactivating the β-catenin pathway. Last author DOI 10.1186/s12935-025-03710-4↗
  2. Exosomal SOX21-AS1 Regulates EREG by Sponging miR-451a and Promotes the Malignancy of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.7150/jca.95014↗
  3. Upregulation of ARHGAP30 attenuates pancreatic cancer progression by inactivating the β-catenin pathway. Last author DOI 10.1186/s12935-020-01288-7↗
  4. Cisplatin-induced non-apoptotic death of pancreatic cancer cells requires mitochondrial cyclophilin-D-p53 signaling. Last author DOI 10.1016/j.bbrc.2013.06.103↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhiyuan Hua · 3 shared papers, 2020–2025 · strength 0.60
  2. Yongping Zhou · 3 shared papers, 2020–2025 · strength 0.60
  3. Liying Wang · 2 shared papers, 2020–2025 · strength 0.39
  4. Yong Yan · 1 shared paper, 2024 · strength 0.21
  5. Bin Xu · 1 shared paper, 2024 · strength 0.21
  6. Fang‐Ming Chen · 1 shared paper, 2020 · strength 0.12
  7. Lei Gong · 1 shared paper, 2013 · strength 0.04
  8. Bo Chen · 1 shared paper, 2013 · strength 0.04
  9. Gaojue Wu · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.